89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
9.05
-0.09 (-0.98%)
Aug 14, 2025, 12:03 PM - Market open
89bio Employees
89bio had 93 employees as of December 31, 2024. The number of employees increased by 23 or 32.86% compared to the previous year.
Employees
93
Change (1Y)
23
Growth (1Y)
32.86%
Revenue / Employee
n/a
Profits / Employee
-$4,840,925
Market Cap
1.34B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 93 | 23 | 32.86% |
| Dec 31, 2023 | 70 | 25 | 55.56% |
| Dec 31, 2022 | 45 | 4 | 9.76% |
| Dec 31, 2021 | 41 | 14 | 51.85% |
| Dec 31, 2020 | 27 | 7 | 35.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ETNB News
- 3 days ago - 89bio: Promising As Pegozafermin Nears Phase 3 Readout - Seeking Alpha
- 6 days ago - 89bio Reports Second Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 9 days ago - 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - 89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - 89bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - 89bio Reports First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 4 months ago - 89bio: A Buy With Strong Market Opportunity In MASH And SHTG - Seeking Alpha
- 5 months ago - 89bio to Participate in the Leerink Partners Global Healthcare Conference - GlobeNewsWire